General description The Apelin C-Terminus Enzyme Immunoassay (EIA) Kit is an in vitro quantitative assay for detecting Apelin C-Terminus peptide based on the principle of Competitive Enzyme Immunoassay. The EIA-APC-1 kit detects all active Apelin
General description The Apelin C-Terminus Enzyme Immunoassay (EIA) Kit is an in vitro quantitative assay for detecting Apelin C-Terminus peptide based on the principle of Competitive Enzyme Immunoassay. The EIA-APC-1 kit detects all active Apelin
General description The Visfatin Enzyme Immunoassay (EIA) Kit is an in vitro quantitative assay for detecting Visfatin peptide based on the principle of Competitive Enzyme Immunoassay. Visfatin, also known as nicotinamide
General description The Visfatin Enzyme Immunoassay (EIA) Kit is an in vitro quantitative assay for detecting Visfatin peptide based on the principle of Competitive Enzyme Immunoassay. Visfatin, also known as nicotinamide
Biochem/physiol Actions CID 2886111 is a D1 dopamine receptor positive allosteric modulator (PAM) that binds to a different allosteric site than other D1 PAMs such as DETQ and compound B.
Biochem/physiol Actions CID 2886111 is a D1 dopamine receptor positive allosteric modulator (PAM) that binds to a different allosteric site than other D1 PAMs such as DETQ and compound B.
Biochem/physiol Actions CID 2886111 is a D1 dopamine receptor positive allosteric modulator (PAM) that binds to a different allosteric site than other D1 PAMs such as DETQ and compound B.
Biochem/physiol Actions CID 2886111 is a D1 dopamine receptor positive allosteric modulator (PAM) that binds to a different allosteric site than other D1 PAMs such as DETQ and compound B.
Biochem/physiol Actions EN450 is a molecular glue degraders of the oncogenic transcription factor NFKB1 that induces ternary complex formation between ubiquitin-conjugating enzyme E2D1 (UBE2D1) and NFKB1. EN450 covalently modifies an allosteric
Biochem/physiol Actions EN450 is a molecular glue degraders of the oncogenic transcription factor NFKB1 that induces ternary complex formation between ubiquitin-conjugating enzyme E2D1 (UBE2D1) and NFKB1. EN450 covalently modifies an allosteric
Biochem/physiol Actions EN450 is a molecular glue degraders of the oncogenic transcription factor NFKB1 that induces ternary complex formation between ubiquitin-conjugating enzyme E2D1 (UBE2D1) and NFKB1. EN450 covalently modifies an allosteric
Biochem/physiol Actions EN450 is a molecular glue degraders of the oncogenic transcription factor NFKB1 that induces ternary complex formation between ubiquitin-conjugating enzyme E2D1 (UBE2D1) and NFKB1. EN450 covalently modifies an allosteric
General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the
General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the
General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the
General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the